Pear Therapeutics isn't meeting the commercialization goals for its prescription digital therapeutics, so it's now seeking strategic alternatives for the business. Prospective buyers can pick up Pear's FDA-cleared products for substance use disorder, opioid use disorder, and insomnia.
We're ready for spring, are you? In our enthusiasm for spring, we're bringing you a special limited time discount of $600 to attend INVEST, the premier healthcare networking event of 2023.
Providence recently launched a program to expand its patients' access to in-home physical therapy. The health system is launching the initiative in partnership with Luna, a provider of in-home outpatient physical therapy that serves patients in nearly 30 states.
Patricia Kelmar, healthcare campaigns director at the Public Interest Research Group, is an advocate for the No Surprises Act. But there's one thing that bothers her: the fact that providers can ask patients to waive their surprise billing protections, she said Tuesday when speaking at the AHIP Medicare, Medicaid, Duals and Commercial Markets Forum in Washington, D.C.
In the first episode, aside from providing an overview of healthcare's latest leadership and layoff news, Senior Reporter Katie Adams interviews Dr. Taha Kass-Hout, who recently became GE Healthcare's chief technology officer, about healthcare's corporate ladder.
No comments